ArticleAmerican journal of hematology2024

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Emanuele Tanzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.